申请人:Roche Palo Alto LLP
公开号:US08119644B2
公开(公告)日:2012-02-21
Compounds of the formula I:
or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted thiadiazolyl, and R2, R3, R4, R5, R6, R7 and R8 are as defined herein. Also disclosed are methods of using the compounds for treating diseases associated with P2X3 and/or a P2X2/3 receptor antagonists and methods of making the compounds.
公式I的化合物或其药学上可接受的盐,其中,R1是可选取代的噻二唑基,R2、R3、R4、R5、R6、R7和R8如本文所定义。还公开了使用这些化合物治疗与P2X3和/或P2X2/3受体拮抗剂相关的疾病的方法以及制备这些化合物的方法。